Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-09 08:14 am Sale |
2023-02-09 | 13G | 10x Genomics, Inc. TXG |
FMR LLC | 8,893,098 8.780% |
-4,385,709 (-33.03%) |
Filing History |
| 2023-02-08 11:17 am Sale |
2022-12-30 | 13G | 10x Genomics, Inc. TXG |
MORGAN STANLEY MS |
9,894,979 10.400% |
-446,774 (-4.32%) |
Filing History |
| 2023-02-01 4:54 pm Purchase |
2022-12-31 | 13G | 10x Genomics, Inc. TXG |
BlackRock Inc. BLK |
5,319,179 5.600% |
327,892 (+6.57%) |
Filing History |
| 2023-01-18 06:24 am Purchase |
2022-12-30 | 13G | 10x Genomics, Inc. TXG |
BAILLIE GIFFORD & CO | 8,602,235 9.000% |
1,723,858 (+25.06%) |
Filing History |
| 2022-09-12 4:29 pm Purchase |
2022-08-31 | 13G | 10x Genomics, Inc. TXG |
MORGAN STANLEY MS |
10,341,753 10.900% |
5,732,995 (+124.39%) |
Filing History |
| 2022-08-09 4:02 pm Sale |
2022-07-31 | 13G | 10x Genomics, Inc. TXG |
BlackRock Inc. BLK |
4,991,287 5.300% |
-5,236,386 (-51.20%) |
Filing History |
| 2022-05-09 3:23 pm Purchase |
2022-04-30 | 13G | 10x Genomics, Inc. TXG |
BlackRock Inc. BLK |
10,227,673 10.900% |
2,209,039 (+27.55%) |
Filing History |
| 2022-02-14 4:11 pm Sale |
2021-12-31 | 13G | 10x Genomics, Inc. TXG |
Venrock Associates VI L.P. | 4,828,247 5.100% |
-3,000,000 (-38.32%) |
Filing History |
| 2022-02-09 3:15 pm Purchase |
2021-12-31 | 13G | 10x Genomics, Inc. TXG |
The Vanguard Group | 7,554,042 8.250% |
1,366,337 (+22.08%) |
Filing History |
| 2022-02-09 10:56 am Sale |
2021-12-31 | 13G | 10x Genomics, Inc. TXG |
MORGAN STANLEY MS |
4,608,758 5.000% |
-1,306,776 (-22.09%) |
Filing History |
| 2022-02-09 09:07 am Sale |
2022-02-08 | 13G | 10x Genomics, Inc. TXG |
FMR LLC | 13,278,807 13.594% |
-467,707 (-3.40%) |
Filing History |
| 2022-02-03 4:41 pm Purchase |
2021-12-31 | 13G | 10x Genomics, Inc. TXG |
BlackRock Inc. BLK |
8,018,634 8.800% |
2,855,614 (+55.31%) |
Filing History |
| 2022-01-18 06:57 am Purchase |
2021-12-31 | 13G | 10x Genomics, Inc. TXG |
BAILLIE GIFFORD & CO | 6,878,377 7.510% |
6,878,377 (New Position) |
Filing History |
| 2021-12-10 08:52 am Sale |
2021-12-09 | 13G | 10x Genomics, Inc. TXG |
FMR LLC | 13,746,514 14.059% |
-2,915,302 (-17.50%) |
Filing History |
| 2021-07-30 5:04 pm Sale |
2021-07-01 | 13D | 10x Genomics, Inc. TXG |
Hindson Benjamin J. | 3,611,410 4.000% |
-438,590 (-10.83%) |
Filing History |
| 2021-07-30 5:01 pm Purchase |
2021-07-06 | 13D | 10x Genomics, Inc. TXG |
Saxonov Serge | 4,851,530 5.300% |
123,879 (+2.62%) |
Filing History |
| 2021-02-16 4:17 pm Sale |
2020-12-31 | 13G | 10x Genomics, Inc. TXG |
Meritech Capital Partners V L.P. | 2,580,975 3.200% |
-1,079,979 (-29.50%) |
Filing History |
| 2021-02-16 4:06 pm Sale |
2020-12-31 | 13G | 10x Genomics, Inc. TXG |
Venrock Associates VI L.P. | 7,828,247 9.100% |
-3,263,569 (-29.42%) |
Filing History |
| 2021-02-16 10:34 am Sale |
2020-12-31 | 13G | 10x Genomics, Inc. TXG |
Foresite Capital Fund I L.P. | 3,753,528 4.700% |
-10,319,121 (-73.33%) |
Filing History |
| 2021-02-16 09:11 am Sale |
2020-12-31 | 13G | 10x Genomics, Inc. TXG |
SB Investment Advisers (UK) Limited | 0 0.000% |
-3,836,232 (Position Closed) |
Filing History |